Compare OIS & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OIS | BWAY |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.3M | 410.4M |
| IPO Year | 2001 | 2019 |
| Metric | OIS | BWAY |
|---|---|---|
| Price | $9.08 | $22.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 891.9K | 110.3K |
| Earning Date | 02-19-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 213.09 |
| EPS | ★ 0.38 | 0.13 |
| Revenue | ★ $655,119,000.00 | $49,094,000.00 |
| Revenue This Year | N/A | $330.76 |
| Revenue Next Year | $3.51 | $22.24 |
| P/E Ratio | ★ $23.87 | $67.21 |
| Revenue Growth | N/A | ★ 27.08 |
| 52 Week Low | $3.08 | $7.84 |
| 52 Week High | $9.19 | $25.65 |
| Indicator | OIS | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 69.39 | 53.51 |
| Support Level | $8.41 | $20.34 |
| Resistance Level | $9.07 | $25.65 |
| Average True Range (ATR) | 0.37 | 1.49 |
| MACD | 0.01 | -0.43 |
| Stochastic Oscillator | 88.48 | 48.40 |
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.